November 26, 2021
ASH Issues Guideline on the Use of HSCT for Sickle Cell Disease
The use of HSCT for sickle cell disease is evolving, and no randomized controlled trials were identified in the evidence review for this guideline In a 2021 clinical guideline issued by the American Society of Hematology and published online Sept. 28 in Blood Advances, eight conditional recommendations are presented for the use of hematopoietic stem...